UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding

PloS one, 2022-09, Vol.17 (9), p.e0274969-e0274969

2022

Volltextzugriff (PDF)

Short-acting β -agonist use and its ability to predict future asthma-related outcomes

Annals of allergy, asthma, & immunology, 2012-12, Vol.109 (6), p.403-407

2012

Volltextzugriff (PDF)

Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients

Therapeutic advances in gastroenterology, 2021, Vol.14, p.1756284821997352-1756284821997352

2021

Volltextzugriff (PDF)

Delayed treatment initiation of oral anticoagulants among Medicare patients with atrial fibrillation

American heart journal plus, 2024-03, Vol.39, p.100369, Article 100369

2024

Volltextzugriff (PDF)

Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease

Thrombosis and haemostasis, 2022-06, Vol.122 (6), p.926-938

2022

Volltextzugriff (PDF)

Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants

Clinical and applied thrombosis/hemostasis, 2019-01, Vol.25, p.1076029619870249-1076029619870249

2019

Volltextzugriff (PDF)

Trends and factors associated with outpatient anticoagulant treatment initiation among VTE patients with active cancer

Thrombosis research, 2023-04, Vol.224, p.52-59

2023

Volltextzugriff (PDF)

Risk of Venous Thromboembolism by Cancer Type: A Network Meta-Analysis

Seminars in thrombosis and hemostasis, 2024-04, Vol.50 (3), p.328-341

2024

Volltextzugriff (PDF)

Payer formulary tier increases of apixaban: how patients respond and potential implications

Current medical research and opinion, 2023-08, Vol.39 (8), p.1-1101

2023

Volltextzugriff (PDF)

Effectiveness and Safety of Extended Treatment Apixaban Versus Low-Molecular-Weight Heparin in Cancer-Associated Venous Thromboembolism

Journal of the National Comprehensive Cancer Network, 2024-08, Vol.22 (6), p.397

2024

Volltextzugriff (PDF)

Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19

Current medical research and opinion, 2022-11, Vol.38 (11), p.1891-1896

2022

Volltextzugriff (PDF)

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients

Journal of the American Geriatrics Society (JAGS), 2019-08, Vol.67 (8), p.1662-1671

2019

Volltextzugriff (PDF)

Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs

The American journal of cardiology, 2022-01, Vol.163, p.43-49

2022

Volltextzugriff (PDF)

Effectiveness and safety of anticoagulants among patients with venous thromboembolism and common cancers or cancers with high venous thromboembolism risk

Future oncology (London, England), 2024-03, Vol.20 (9), p.521-532

2024

Volltextzugriff (PDF)

Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal disease

Current medical research and opinion, 2024-03, Vol.40 (3), p.545-553

2024

Volltextzugriff (PDF)

Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity

Advances in therapy, 2023-03, Vol.40 (3), p.887-902

2023

Volltextzugriff (PDF)

Associations Between COPD Severity and Work Productivity, Health-Related Quality of Life, and Health Care Resource Use: A Cross-Sectional Analysis of National Survey Data

Journal of occupational and environmental medicine, 2016-06, Vol.58 (6), p.e191-e197

2016

Volltextzugriff (PDF)

Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status

Advances in therapy, 2021-11, Vol.38 (11), p.5519-5533

2021

Volltextzugriff (PDF)

Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus

Mayo Clinic proceedings, 2020-05, Vol.95 (5), p.929-943

2020

Volltextzugriff (PDF)

COPD exacerbation frequency and its association with health care resource utilization and costs

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10 (Issue 1), p.2609-2618

2015

Volltextzugriff (PDF)

Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences

Advances in therapy, 2023-04, Vol.40 (4), p.1705-1735

2023

Volltextzugriff (PDF)

Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population

International journal of chronic obstructive pulmonary disease, 2017-01, Vol.12, p.735-744

2017

Volltextzugriff (PDF)

Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2022-05, Vol.22 (3), p.333-343

2022

Volltextzugriff (PDF)

Continuation with apixaban treatment is associated with lower risk for hospitalization and medical costs among elderly patients

Current medical research and opinion, 2019-10, Vol.35 (10), p.1769-1776

2019

Volltextzugriff (PDF)

Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA

Journal of medical economics, 2020-12, Vol.23 (12), p.1389-1400

2020

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding

Short-acting β -agonist use and its ability to predict future asthma-related outcomes

Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients

Delayed treatment initiation of oral anticoagulants among Medicare patients with atrial fibrillation

Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease

Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants

Trends and factors associated with outpatient anticoagulant treatment initiation among VTE patients with active cancer

Risk of Venous Thromboembolism by Cancer Type: A Network Meta-Analysis

Payer formulary tier increases of apixaban: how patients respond and potential implications

Effectiveness and Safety of Extended Treatment Apixaban Versus Low-Molecular-Weight Heparin in Cancer-Associated Venous Thromboembolism

Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients

Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs

Effectiveness and safety of anticoagulants among patients with venous thromboembolism and common cancers or cancers with high venous thromboembolism risk

Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal disease

Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity

Associations Between COPD Severity and Work Productivity, Health-Related Quality of Life, and Health Care Resource Use: A Cross-Sectional Analysis of National Survey Data

Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status

Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus

COPD exacerbation frequency and its association with health care resource utilization and costs

Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences

Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population

Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA

Continuation with apixaban treatment is associated with lower risk for hospitalization and medical costs among elderly patients

Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA

Suchergebnisse filtern